NCT06218602 2026-04-15
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
M.D. Anderson Cancer Center
Phase 2 Recruiting
Clinical Trials
16 trialsNCT04038619 2026-03-20
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04975217 2026-03-20
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03819296 2026-03-11
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT07042438 2026-03-05
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
City of Hope Medical Center
Phase 2 Recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT05533983 2025-12-03
NIVO-FMT
Asan Medical Center
Phase NA Recruiting
NCT06206707 2025-11-17
Immunobiome
University of Aarhus
Phase NA Recruiting
NCT05690048 2025-08-06
FLORA
University Hospital Heidelberg
Phase 2 Recruiting
NCT06346093 2025-06-10
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
Changhai Hospital
Phase NA Recruiting
NCT05251389 2025-03-10
FMT to Convert Response to Immunotherapy
The Netherlands Cancer Institute
Phase 1/2 Recruiting
NCT04721041 2025-03-06
Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
The Second Hospital of Nanjing Medical University
Phase NA Recruiting
NCT06405113 2025-02-20
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Changzhou No.2 People's Hospital
Phase 2 Recruiting
NCT06403111 2024-12-20
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
Changzhou No.2 People's Hospital
Phase 2 Recruiting
NCT05502913 2023-10-02
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
Soroka University Medical Center
Phase 2 Recruiting
NCT04935684 2023-03-01
TMF-Allo
University Hospital, Clermont-Ferrand
Phase 2 Recruiting